COMMUNIQUÉS West-GlobeNewswire

Renaissance Recovery Expands in Florida, Increasing Capacity and Improving Access to Addiction Treatment
21/08/2025
In response to the growing need for addiction recovery services, Renaissance Recovery is expanding its Florida facility with 16 new available spots. LANTANA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Renaissance Recovery [...]
Regional Health Properties Reports Second Quarter & Six Month 2025 Financial Results
21/08/2025
ATLANTA, GA , Aug. 21, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA) (OTCQB:RHEPZ, a self-managed healthcare real [...]
Premier Health Reports 2025 Third Quarter Results
21/08/2025
MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Company ”), a leading Canadian Healthtech company, announces it has filed its unaudited Quarterly Consolidated Financial [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21/08/2025
NOVATO, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Nusano Cuts Ribbon on State-of-the-Art Radioisotope Production Facility
21/08/2025
Utah Governor Spencer Cox opens 190,000-square-foot building Nusano platform capable of producing more than 40 different radioisotopes for healthcare and industry New supplies of radioisotopes urgently needed for new [...]
BioSyent Releases Financial Results for Q2 and H1 2025
21/08/2025
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June 30, 2025. Key highlights [...]
BioSyent Declares Third Quarter 2025 Dividend
21/08/2025
MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common [...]
Oculis Reports Q2 2025 Financial Results and Provides Company Update
21/08/2025
ZUG, Switzerland, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology. OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with [...]
Oculis Reports Q2 2025 Financial Results and Provides Company Update
21/08/2025
Focused execution in Q2 2025 to advance Oculis’ pipeline in ophthalmology and neuro-ophthalmology OCS-01: Both pivotal Ph3 DIAMOND trials are fully enrolled, with topline results expected in Q2 2026 for the first [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
21/08/2025
CONSHOHOCKEN, Pa., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Terns Pharmaceuticals to Host an Educational Webinar on TERN-701 for Investors in Advance of Phase 1 Data Expected in Fourth Quarter 2025
21/08/2025
Webinar to be held on Wednesday, September 3, 2025 at 4:30 p.m. ET FOSTER CITY, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage [...]
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
21/08/2025
CAMBRIDGE, Mass., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced its [...]
AVITA Medical Announces September Investor Conference Participation
21/08/2025
VALENCIA, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced that senior [...]
Health Catalyst to Participate in Upcoming Investor Conferences
21/08/2025
SALT LAKE CITY, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]
Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
21/08/2025
Manuscript featured in leading open-access scientific journal Alzheimer’s Research & Therapy SARASOTA, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified [...]
PathAI and Moffitt Cancer Center Announce Strategic Collaboration to Deploy the AISight® Dx Digital Pathology Platform and Advance AI Diagnostics
21/08/2025
Partnership includes joint collaboration initiatives to improve precision medicine and accelerate innovation in cancer pathology BOSTON, Mass., and TAMPA, Fla., Aug. 21, 2025 (GLOBE NEWSWIRE) -- PathAI , a global leader [...]
Applied StemCell Appoints Dolores Baksh, Ph.D., as Chief Executive Officer
21/08/2025
MILPITAS, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Applied StemCell , a genome engineering product and services company, announced today the appointment of Dolores Baksh, Ph.D., as Chief Executive Officer. Company [...]
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
21/08/2025
PITTSBURGH, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced an update on development plans for KB707, the Company’s [...]
BriaCell Announces Proposed Effective Date of Share Consolidation
21/08/2025
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“ BriaCell ” or the “ Company ”), a clinical-stage biotechnology [...]

Pages